Ferozsons Laboratories Limited

  • LANGUAGES
    • English English
    • اردو اردو
  • About Us
    • History
    • Company Profile
    • Vision, Mission & Values
    • Message From CEO
    • Board of Directors
    • Contact Us
  • Partnerships
  • Product Portfolio
    • Product List
    • Pharmaceuticals
    • Medical Technologies
    • Exports
  • Investors
    • Company Profile
    • Governance
      • Corporate Briefing Session
        • Notice of Corporate Briefing Session 2025
        • Corporate Briefing Session Presentation 2025
      • AGM 25-10-2025
      • Board of Directors
      • Shareholding Pattern
      • Name of Auditor & Legal Advisor
    • Video Message from CEO
    • Investor Relations
      • Online Form & Contact Person
      • Notices of General Meetings, Dividend / Bonus Declarations
      • Sitemap
      • Search
    • Media
      • Awards
      • Memberships
      • News & Updates
      • Website Last Updated
    • Election of Directors
      • Notice of Election of Directors
      • Detail of Submitted Proxies
      • Profile of Contesting Candidates
      • Proxy Form
      • Ballot Paper
    • Investor Information
      • PSX Symbol
      • Financial Ratios
      • Statement on Gender Pay Gap
      • Share Registrar
      • Free Float 31-12-2025
      • Code of Conduct
    • Shareholding Information
      • List of Non CNIC Shareholders
      • List of Unclaimed Dividends And Shares
      • Share Price
    • Financial Statements
      • Annual Reports
      • Interim Accounts
      • Financial Reports
    • Compliance Certificate
    • EHS Policy
    • Quality Policy
    • Other Information
      • AGM Voting Results
  • Patients
    • Disease Info
    • Drug Safety
    • Send Query
  • Physicians
  • CSR
  • Press & Media
    • Videos
    • Statement on Remdesivir
    • Statement on Lenacapavir
  • Home
  • Public
  • Coronavirus disease 2019
April 19, 2026

Coronavirus disease 2019

developers
Friday, 03 April 2026 / Published in Public

Coronavirus disease 2019

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

  • Tweet

What you can read next

Technologie en de toekomst van gokken hoe innovatie alles verandert
Cultuur en gokken de verborgen geschiedenis van casino's in Nederland
Legal Aspects of Gambling in Greece What You Need to Know
  • About Us

  • Profile of the Company
  • Board of Directors
  • Our Vision, Mission & Values Statement
  • History
  • Message from CEO
  • Contact Us

  • Partnerships

  • Patients

  • Disease Info
  • Send Query
  • Drug Safety
  • Physicians

  • CSR

  • Careers

  • Products Portfolio

  • Pharma & OTC
  • Medical Technologies
  • Exports
  • Investors

  • Awards
  • Election of Directors
  • Investor Information

    Registered Office

    Ferozsons Laboratories Limited 197-A,
    The Mall,Rawalpindi,Rawalpindi-42000
    +92-51-4252150-53/55
    +92-51-4252152-57
    www.ferozsons-labs.com
    info@ferozsons-labs.com

    Head Office

    5 KM Sundar Raiwind Road, Raiwind,
    Lahore, Pakistan
    +92-42-36026700
    +92-42-36026702
    info@ferozsons-labs.com, info@bfbio.com

    Pharma Factory

    P.O.Ferozsons, Amangarh - Nowshera
    (Khyber Pakhtunkhwa)
    +92-923-614295, 610159
    +92-923-611302
    info@ferozsons-labs.com

   

© Copyright Ferozsons Laboratories Limited 2004 - 2024 all rights reserved.
Designed & Developed by A2Z Creatorz
Design Update by David Torrone & Athanasios Anagnostopoulos

TOP